Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations.
Author | |
---|---|
Abstract | :
A poor response to erythropoiesis-stimulating agents such as darbepoetin alfa has been associated with adverse outcomes in patients with diabetes mellitus, chronic kidney disease, and anemia; whether this is also true in heart failure is unclear. |
Year of Publication | :
2018
|
Journal | :
Circulation. Heart failure
|
Volume | :
11
|
Issue | :
2
|
Number of Pages | :
e004431
|
ISSN Number | :
1941-3289
|
URL | :
http://circheartfailure.ahajournals.org/cgi/pmidlookup?view=long&pmid=29367268
|
DOI | :
10.1161/CIRCHEARTFAILURE.117.004431
|
Short Title | :
Circ Heart Fail
|
Download citation |